Resources | NITAG RESOURCE CENTER

2024 ∙ NACI

NACI Updated recommendations on human papillomavirus vaccines

2023 ∙ Guo, Jianming Guo, Shuyan Dong, Siping

Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis

2023 ∙ Yuan, D. Liu, S. Liu, Y. Ouyang, F. Ai, W. Shi, L. Liu, X. Qiu, T. Wang, B. Zhou, Y.

HPV Infection Profiles among People Living with HIV and HPV Vaccine Acceptance among Individuals with Different HIV Infection Statuses in China: A Systematic Meta-Analysis

2022 ∙ Wang, D. Wu, J. Du, J. Ong, H. Tang, B. Dozier, M. Weller, D. Campbell, C.

Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature

2022 ∙ Bai, Y. Ip, P. Chan, K. Ngan, H. Yip, P.

HPV Vaccination Intentions of Female Students in Chinese Universities: A Systematic Literature Review and Meta-Analysis

2021 ∙ Shi, W. Cheng, X. Wang, H. Zang, X. Chen, T.

Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies

2017 ∙ Wong, C. K. H. Liao, Q. Guo, V. Y. W. Xin, Y. Lam, C. L. K.

Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review

2017 ∙ NACI

NACI Literature Review for HPV Immunization of Immunocompromised Populations

2015 ∙ NACI

Update on the recommended Human Papillomavirus (HPV) vaccine immunization schedule

2010 ∙ Joanne Langley, Tara Harris, Bryna Warshawsky, Shalini Desai, Mahnaz FarhangMehr, Shainoor Ismail

Canada’s National Advisory Committee on Immunization (NACI): Evidence-based decision-making on vaccines and immunization